Literature DB >> 31753246

Drug-Induced Liver Injury Resources and Reporting for the Clinician.

Marisa Isaacson1, Michael Babich2.   

Abstract

Although many risk factors for developing drug-induced liver injury (DILI) have been identified and more than 1000 medications and herbal and dietary supplements are known to cause liver dysfunction, idiosyncratic drug reactions remain unpredictable and erratic. Varying effects of individual drugs on the event cascade and patient genetic polymorphisms lead to different clinical presentations. Mechanisms and causality scales have been developed to guide the clinician in diagnosis, and several databases and registries are available for reference and reporting. We identify and summarize the resources available to clinicians to help diagnose, manage, and report DILI and to identify hepatotoxic drugs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-induced liver injury; Hepatotoxicity; Reporting; Resources

Mesh:

Year:  2019        PMID: 31753246     DOI: 10.1016/j.cld.2019.09.010

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  1 in total

1.  Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study.

Authors:  Dongxuan Li; Jie Dong; Xin Xi; Guili Huang; Wenjun Li; Cheng Chen; Jun Liu; Qian Du; Songqing Liu
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.